196 related articles for article (PubMed ID: 12483242)
1. Understanding the hypercarcinogenic state in chronic hepatitis: a clue to the prevention of human hepatocellular carcinoma.
Hino O; Kajino K; Umeda T; Arakawa Y
J Gastroenterol; 2002; 37(11):883-7. PubMed ID: 12483242
[TBL] [Abstract][Full Text] [Related]
2. Intentional delay of human hepatocarcinogenesis due to suppression of chronic hepatitis.
Hino O
Intervirology; 2005; 48(1):6-9. PubMed ID: 15785083
[TBL] [Abstract][Full Text] [Related]
3. Molecular aspects of human hepatocarcinogenesis mediated by inflammation: from hypercarcinogenic state to normo- or hypocarcinogenic state.
Umeda T; Hino O
Oncology; 2002; 62 Suppl 1():38-42. PubMed ID: 11868783
[TBL] [Abstract][Full Text] [Related]
4. The pathogenesis of hepatocellular carcinoma is multifactorial event. Novel immunological treatment in prospect.
Marotta F; Vangieri B; Cecere A; Gattoni A
Clin Ter; 2004 May; 155(5):187-99. PubMed ID: 15344567
[TBL] [Abstract][Full Text] [Related]
5. Comparative analysis of HBV and HCV infection in hepatocellular carcinoma and chronic liver disease--an autopsy based study.
Vaiphei K; Pal NS; Arora SK
Indian J Pathol Microbiol; 2006 Jul; 49(3):357-61. PubMed ID: 17001884
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis B virus in hepatocarcinogenesis.
Feitelson MA
J Cell Physiol; 1999 Nov; 181(2):188-202. PubMed ID: 10497299
[TBL] [Abstract][Full Text] [Related]
7. [Molecular mechanism of hepatocarcinogenesis].
Imazeki F; Saisho H
Gan To Kagaku Ryoho; 1999 Dec; 26(14):2154-61. PubMed ID: 10635298
[TBL] [Abstract][Full Text] [Related]
8. TP53 mutations and hepatocellular carcinoma: insights into the etiology and pathogenesis of liver cancer.
Hussain SP; Schwank J; Staib F; Wang XW; Harris CC
Oncogene; 2007 Apr; 26(15):2166-76. PubMed ID: 17401425
[TBL] [Abstract][Full Text] [Related]
9. [Molecular genetic and epigenetic mechanisms of hepatocarcinogenesis].
Xue KX
Ai Zheng; 2005 Jun; 24(6):757-68. PubMed ID: 15946497
[TBL] [Abstract][Full Text] [Related]
10. Pathobiologic effects of hepatitis C.
Gerber MA
J Hepatol; 1995; 22(1 Suppl):83-6. PubMed ID: 7602083
[TBL] [Abstract][Full Text] [Related]
11. Molecular targets for therapy of hepatitis B virus-induced hepatocellular carcinoma.
Tharayil VS; Roberts LR
Minerva Gastroenterol Dietol; 2006 Dec; 52(4):387-406. PubMed ID: 17108869
[TBL] [Abstract][Full Text] [Related]
12. Hepatocellular carcinoma development in cirrhosis.
Okuda H
Best Pract Res Clin Gastroenterol; 2007; 21(1):161-73. PubMed ID: 17223503
[TBL] [Abstract][Full Text] [Related]
13. [Clinical and molecular correlation between chronic hepatitis and hepatocellular carcinoma induced by hepatitis B virus].
Shapiro IIa; Shabrov AV; Karev VE; Leenman EE; Kvetnoĭ IM; Tsinzerling VA; Sologub TV
Arkh Patol; 2005; 67(2):6-10. PubMed ID: 15938110
[TBL] [Abstract][Full Text] [Related]
14. Preneoplastic conditions of the liver.
Riegler JL
Semin Gastrointest Dis; 1996 Apr; 7(2):74-87. PubMed ID: 8705261
[TBL] [Abstract][Full Text] [Related]
15. [Epidemiology, natural history and pathogenesis of hepatocellular carcinoma].
Maillard E
Cancer Radiother; 2011 Feb; 15(1):3-6. PubMed ID: 21239205
[TBL] [Abstract][Full Text] [Related]
16. Molecular therapy and prevention of hepatocellular carcinoma.
Blum HE
Hepatobiliary Pancreat Dis Int; 2003 Feb; 2(1):11-22. PubMed ID: 14599923
[TBL] [Abstract][Full Text] [Related]
17. Review of genetic and epigenetic alterations in hepatocarcinogenesis.
Herath NI; Leggett BA; MacDonald GA
J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):15-21. PubMed ID: 16706806
[TBL] [Abstract][Full Text] [Related]
18. Ursodiol use is possibly associated with lower incidence of hepatocellular carcinoma in hepatitis C virus-associated liver cirrhosis.
Tarao K; Fujiyama S; Ohkawa S; Miyakawa K; Tamai S; Hirokawa S; Masaki T; Tanaka K
Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):164-9. PubMed ID: 15668491
[TBL] [Abstract][Full Text] [Related]
19. HBV DNA integration and HBV-transcript expression in non-B, non-C hepatocellular carcinoma in Japan.
Tamori A; Nishiguchi S; Kubo S; Narimatsu T; Habu D; Takeda T; Hirohashi K; Shiomi S
J Med Virol; 2003 Dec; 71(4):492-8. PubMed ID: 14556260
[TBL] [Abstract][Full Text] [Related]
20. Characteristics and outcome of patients with dual hepatitis B and C-associated hepatocellular carcinoma: are they different from patients with single virus infection?
Huo TI; Huang YH; Hsia CY; Su CW; Lin HC; Hsu CY; Lee PC; Lui WY; Loong CC; Chiang JH; Chiou YY; Lee SD
Liver Int; 2009 May; 29(5):767-73. PubMed ID: 19018974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
